| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/2013 | US8513302 Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| 08/20/2013 | US8513301 Kind of piperphentonamine hydrochloride lyophilized powder for injection and preparation and use thereof |
| 08/20/2013 | US8513300 Allergic rhinitis, asthma, rheumatoid arthritis or an autoimmune disease; Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC) as delivery agent |
| 08/20/2013 | US8513299 Sleep efficiency |
| 08/20/2013 | US8513298 Inhibitors of flaviviridae viruses |
| 08/20/2013 | US8513297 Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 08/20/2013 | US8513296 Pharmaceutical composition |
| 08/20/2013 | US8513295 Viral and fungal inhibitors |
| 08/20/2013 | US8513294 Substituted imidazole derivatives and methods of use thereof for treating cancer |
| 08/20/2013 | US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal |
| 08/20/2013 | US8513292 Compositions and methods for the treatment of cancer |
| 08/20/2013 | US8513291 Cytochrome P450 inhibitors and uses thereof |
| 08/20/2013 | US8513290 Method for preparing largazole analogs and uses thereof |
| 08/20/2013 | US8513289 P38 kinase inhibiting agents |
| 08/20/2013 | US8513288 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 08/20/2013 | US8513287 Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| 08/20/2013 | US8513285 3 or 4-substituted piperidine compounds |
| 08/20/2013 | US8513284 Fused pyridine and pyrazine derivatives as kinase inhibitors |
| 08/20/2013 | US8513283 Spiro substituted compounds as angiogenesis inhibitors |
| 08/20/2013 | US8513282 Modulators of cystic fibrosis transmembrane conductance regulator |
| 08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 08/20/2013 | US8513280 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 08/20/2013 | US8513279 Quinuclidine derivatives and medicinal compositions containing the same |
| 08/20/2013 | US8513278 Parenteral dextrose formulation of clopidogrel |
| 08/20/2013 | US8513277 Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof |
| 08/20/2013 | US8513276 Imidazo[1,2-a]pyridine compounds for use in treating cancer |
| 08/20/2013 | US8513275 Forms of rifaximin and uses thereof |
| 08/20/2013 | US8513274 Ellipticine compounds for treating obesity |
| 08/20/2013 | US8513273 Arylethynyl derivatives |
| 08/20/2013 | US8513272 Forms of a fused pyrrolocarbazole compound |
| 08/20/2013 | US8513270 Substituted heterocycles as Janus kinase inhibitors |
| 08/20/2013 | US8513269 Preparation for external use |
| 08/20/2013 | US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy |
| 08/20/2013 | US8513267 4-anilinoquinazoline derivatives with adenosine-kinase inhibitor properties |
| 08/20/2013 | US8513266 Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha |
| 08/20/2013 | US8513265 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists |
| 08/20/2013 | US8513264 Combination therapy for the treatment of diabetes and related conditions |
| 08/20/2013 | US8513263 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors |
| 08/20/2013 | US8513262 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/20/2013 | US8513261 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 08/20/2013 | US8513259 Non-sedating antihistamine injection formulations and methods of use thereof |
| 08/20/2013 | US8513258 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
| 08/20/2013 | US8513257 Ureas and their use in the treatment of heart failure |
| 08/20/2013 | US8513256 Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 08/20/2013 | US8513255 Substituted dihydroquinazolines |
| 08/20/2013 | US8513254 Method of treating atrial fibrillation |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/20/2013 | US8513252 Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 08/20/2013 | US8513251 Pyridazinone compounds |
| 08/20/2013 | US8513250 Imidazolo-heteroaryl derivatives with antibacterial properties |
| 08/20/2013 | US8513249 Methods and compositions for safe and effective treatment of erythema |
| 08/20/2013 | US8513248 5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators |
| 08/20/2013 | US8513247 Methods and compositions for safe and effective treatment of erythema |
| 08/20/2013 | US8513245 Pharmaceutical composition for reducing the area of myocardial infarction and its use |
| 08/20/2013 | US8513244 Neprilysin inhibitors |
| 08/20/2013 | US8513243 ABT-263 crystalline forms |
| 08/20/2013 | US8513242 Pyrimidine compounds and methods of making and using same |
| 08/20/2013 | US8513241 3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 08/20/2013 | US8513240 Micronized tanaproget and compositions containing same |
| 08/20/2013 | US8513239 Chiral cis-imidazolines |
| 08/20/2013 | US8513238 Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513236 Pterostilbene cocrystals |
| 08/20/2013 | US8513235 Homocysteine synthase inhibitor |
| 08/20/2013 | US8513233 Pyrimidinyl-propionic acid derivatives and their use as PPAR agonists |
| 08/20/2013 | US8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands |
| 08/20/2013 | US8513231 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 08/20/2013 | US8513230 Nuclear transport modulators and uses thereof |
| 08/20/2013 | US8513229 4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2 |
| 08/20/2013 | US8513228 Crystalline form of antiprogestin CDB-4124 |
| 08/20/2013 | US8513227 Inhibition of inflammatory cytokine production with tanshinones |
| 08/20/2013 | US8513226 Simultaneous method for the preparation of a mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine |
| 08/20/2013 | US8513225 Composition and method for topical treatment of skin lesions |
| 08/20/2013 | US8513224 Crystalline form C of tigecycline dihydrochloride and methods for its preparation |
| 08/20/2013 | US8513223 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 08/20/2013 | US8513222 Methods of treating fibrosis, cancer and vascular injuries |
| 08/20/2013 | US8513220 Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity |
| 08/20/2013 | US8513219 Substituted phosphonates and their use in decreasing amyloid aggregates |
| 08/20/2013 | US8513218 Derivatives of 1-amino-2-cyclopropylethylboronic acid |
| 08/20/2013 | US8513216 Polysaccharide gel formulation having increased longevity |
| 08/20/2013 | US8513214 C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV |
| 08/20/2013 | US8513205 Potent chimeric NRTI-NNRTI bifunctional inhibitors of HIV-1 reverse transcriptase |
| 08/20/2013 | US8513204 Compositions comprising amphotericin B, mehods and systems |
| 08/20/2013 | US8513202 Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate |
| 08/20/2013 | US8513198 Pharmaceutical formulation for reducing pain |
| 08/20/2013 | US8513196 Treatment of T-cell mediated diseases |
| 08/20/2013 | US8513190 Method of regulating glucose metabolism, and reagents related thereto |
| 08/20/2013 | US8513188 Formulations comprising cyclic compounds |
| 08/20/2013 | US8513181 Substances and compositions for enhancing DNA repair and methods of use |
| 08/20/2013 | US8513028 Use of MLN51 gene and protein |
| 08/20/2013 | US8513027 Method of identifying an inhibitor of the prostanoid EP4 receptor |
| 08/20/2013 | US8513025 Detecting succinylacetone |
| 08/20/2013 | US8512994 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512993 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512969 Methods for analyzing a heparin sample |
| 08/20/2013 | US8512767 Pharmaceutical compositions |
| 08/20/2013 | US8512760 Nano-particle dispersions |
| 08/20/2013 | US8512759 Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles |
| 08/20/2013 | US8512758 Powder composition |
| 08/20/2013 | US8512753 Micronized particles of low-dosage strength active agents for powder formulations for inhalation |